Novocure’s commercial products have been approved in several countries for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. Novocure is conducting and has completed clinical trials of TTFields for the treatment of brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.
Novocure
Novocure is a global oncology company working to extend survival in some of the most aggressive cancers by developing and commercializing its innovative TTFields therapy.
